PT  - JOURNAL ARTICLE
AU  - Bulfamante, Gaetano Pietro
AU  - Perrucci, Gianluca Lorenzo
AU  - Falleni, Monica
AU  - Sommariva, Elena
AU  - Tosi, Delfina
AU  - Martinelli, Carla
AU  - Songia, Paola
AU  - Poggio, Paolo
AU  - Carugo, Stefano
AU  - Pompilio, Giulio
TI  - Evidence of SARS-CoV-2 transcriptional activity in cardiomyocytes of COVID-19 patients without clinical signs of cardiac involvement
AID  - 10.1101/2020.08.24.20170175
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.24.20170175
4099  - http://medrxiv.org/content/early/2020/08/26/2020.08.24.20170175.short
4100  - http://medrxiv.org/content/early/2020/08/26/2020.08.24.20170175.full
AB  - Background Cardiovascular complication in patients affected by novel Coronavirus respiratory disease (COVID-19) are increasingly recognized. However, although a cardiac tropism of SARS-CoV-2 for inflammatory cells in autopsy heart samples of COVID-19 patients has been reported, the presence of the virus in cardiomyocytes has not been documented yet.Methods We investigated for SARS-CoV-2 presence in heart tissue autopsies of 6 consecutive COVID-19 patients deceased for respiratory failure showing no signs of cardiac involvement and with no history of heart disease. Cardiac autopsy samples were analysed by digital PCR, Western blot, immunohistochemistry, immunofluorescence, RNAScope, and transmission electron microscopy assays.Results The presence of SARS-CoV-2 into cardiomyocytes was invariably detected. A variable pattern of cardiomyocytes injury was observed, spanning from the absence of cell death and subcellular alterations hallmarks to the intracellular oedema and sarcomere ruptures. In addition, we found active viral transcription in cardiomyocytes, by detecting both sense and antisense SARS-CoV-2 spike RNA.Conclusions In this analysis of autopsy cases, the presence of SARS-CoV-2 into cardiomyocytes, determining variable patterns of intracellular involvement, has been documented. All these findings suggest the need of a cardiologic surveillance even in survived COVID-19 patients not displaying a cardiac phenotype, in order to monitor potential long-term cardiac sequelae.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Italian Ministry of Health, RC-2019-CA1E-2755807.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval Approval was not required (GU n. 72 26/03/2012, page 49).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe raw dataset is deposited in Zenodo web site, and available after e-mail request to the corresponding author. https://dx.doi.org/10.5281/zenodo.3974891